Johnson & Johnson Reports Q4 and Full-Year 2023 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Johnson & Johnson (JNJ) tops revenue estimates, reiterates forecast
January 23, 2024 6:27 AM ESTJohnson & Johnson's (NYSE: JNJ) reported today fourth-quarter results that exceeded analyst expectations.
Adjusted earnings per share (EPS) came in at $2.29, slightly surpassing the average analyst estimate of $2.28. The company also reported sales of $21.40 billion for the quarter, beating the estimated $21.00 billion.
Looking ahead,... More
Johnson & Johnson (JNJ) Tops Q4 EPS by 1c, Beats on Revenue; Reaffirms FY24 Growth Targets
January 23, 2024 6:20 AM EST(Updated - January 23, 2024 6:22 AM EST)
Johnson & Johnson (NYSE: JNJ) reported Q4 EPS of $2.29, $0.01 better than the analyst estimate of $2.28. Revenue for the quarter came in at $21.4 billion versus the consensus estimate of $21 billion.
The company re-confirms guidance for 2024 with operational sales growth of... More
